Medpace Holdings (MEDP)

Medpace offers services across areas such as clinical trial management, regulatory affairs, medical monitoring, data management, biostatistics, pharmacovigilance, and clinical operations. It also provides specialized support through central laboratory, bioanalytical laboratory, imaging, and other ancillary capabilities. This integrated model is designed to reduce the need for customers to coordinate multiple vendors during complex studies.

The company is headquartered in Cincinnati, Ohio, and operates across major clinical research markets in North America, Europe, Asia-Pacific, Latin America, Africa, and Australia. Its global footprint allows it to recruit patients, manage investigator sites, and conduct trials across different healthcare systems and regulatory environments.

Founded more than three decades ago, Medpace has built a reputation around a therapeutically focused and physician-led operating approach. In the broader healthcare market, it competes with other CROs that benefit from the long-term trend of drug developers outsourcing clinical development work. For investors, Medpace represents exposure to clinical research spending rather than direct ownership of a specific drug pipeline.